Heparan sulfate (HS) plays critical roles in a variety of developmental, physiological, and pathogenic processes due to its ability to interact in a structure-dependent manner with numerous growth factors that participate in cellular signaling. The divergent structures of HS glycosaminoglycans are the result of the coordinate actions of several N-and O-sulfotransferases, C5-epimerase, and 6-O-endosulfatases. We have shown that 6-O-sulfation of the glucosamine residues in HS are catalyzed by the sulfotransferases HS6ST-1, -2, and -3. To determine the biological and physiological importance of HS6ST-1, we now describe the creation of transgenic mice that lack this sulfotransferase. Most of our HS6ST-1-null mice died between embryonic day 15.5 and the perinatal stage, and those mice that survived were considerably smaller than their wild-type littermates. Some of these HS6ST-1-null mice exhibited development abnormalities, and histochemical and molecular analyses of these mice revealed an ϳ50% reduction in the number of fetal microvessels in the labyrinthine zone of the placenta relative to that in the wild-type mice. Because we observed a modest reduction in VEGF-A mRNA and protein in the tissues of HS6ST-1-null mice, an HS-dependent defect in cytokine signaling probably contributes to increased embryonic lethality and decreased growth. Biochemical studies of the HS chains isolated from various organs of our HS6ST-1-null mice revealed a marked reduction of GlcNAc(6SO 4 ) and HexA-GlcNSO 3 (6SO 4 ) levels and a reduced ability to bind Wnt2. Thus, despite the presence of three closely related 6-O-sulfotransferase genes in the mouse genome, HS6ST-1 is the primary one used in HS biosynthesis in most tissues.
Heparan sulfate (HS)2 proteoglycans on the cell surfaces interact with numerous growth factors, morphogens, receptors, and extracellular matrix proteins. These complex interactions regulate the activity, gradient formation, and stability of many receptor-ligand interactions. Thus, HS has important functions in a variety of developmental, morphogenetic, and pathogenic processes (1-3). The specificities of the interactions between HS and ligands are thought to be due, at least in part, to the fine structure of HS characterized by the specific localized patterns of sulfates and the hexuronic acid isoform residues (4 -8). The fine and divergent structures of HS are generated in the Golgi apparatus through the coordinate actions of HS modification enzymes, namely N-deacetylase/N-sulfotransferases (NDSTs), Hsepi (C5-epimerase), and 2-O-, 6-O-, and 3-O-sulfotransferases, following the biosynthesis of the HS backbone structure comprising alternating GlcA and GlcNAc residues (9, 10). Further modification of HS occurs at the cell surface by the action of 6-O-endosulfatase (11-13). The localization of some of these HS modification enzymes to the Golgi may be facilitated by their tendency to form multienzyme complexes, as shown in the case of Hsepi and HS2ST (HS 2-O-sulfotransferase) (14, 15). These modification enzymes, with...